发明授权
- 专利标题： Compositions and methods for inhibition of cathepsins
- 专利标题（中）： 用于抑制组织蛋白酶的组合物和方法
-
申请号： US14505165申请日： 2014-10-02
-
公开(公告)号： US09458103B2公开(公告)日： 2016-10-04
- 发明人: David J. Chaplin , Kishore Kumar Gaddale Devanna , Erica Parker , Kevin G. Pinney , Jiangli Song , Mary L. Trawick
- 申请人： OXiGENE, Inc. , Baylor University
- 申请人地址： US CA South San Francisco US TX Waco
- 专利权人： Mateon Therapeutics, Inc.,Baylor University
- 当前专利权人： Mateon Therapeutics, Inc.,Baylor University
- 当前专利权人地址： US CA South San Francisco US TX Waco
- 代理机构： Shay Glenn LLP
- 主分类号： C07C337/08
- IPC分类号： C07C337/08 ; C07C49/786
摘要：
This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.
公开/授权文献
- US20150031915A1 Compositions and Methods for Inhibition of Cathepsins 公开/授权日：2015-01-29
信息查询
